{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:57:39Z","timestamp":1773154659811,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> CLDN10, an important component of the tight junctions of epithelial cells, plays a crucial role in a variety of tumors. The effect of CLDN10 expression in gastric cancer, however, has yet to be elucidated.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Differential expression of CLDN10 at the mRNA and protein levels was evaluated using Oncomine, ULCAN, HPA and TIMER2.0 databases. Real-time polymerase chain reaction (RT-PCR) was utilized to further verify the expression of CLDN10 <jats:italic>in vitro<\/jats:italic>. Correlations between CLDN10 expression and clinical outcomes of gastric cancer were explored by Kaplan-Meier Plotter. Gene set enrichment analysis (GSEA) and protein-protein interaction (PPI) were performed <jats:italic>via<\/jats:italic> LinkedOmics and GeneMANIA. The correlations between CLDN10 expression and immune cell infiltration and somatic copy number alternations (SCNA) in gastric cancer were explored by TIMER2.0 and GEPIA2.0.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> CLDN10 expression was lower in gastric cancer compared to adjacent normal tissues, and associated with better prognosis. CLDN10 also showed significant differences at different T stages, Lauren classification, treatments and HER2 status. PPI and GSEA analysis showed that CLDN10 might be involved in signal transmission, transmembrane transport and metabolism. In some major immune cells, low expression of CLDN10 was associated with increased levels of immune cell infiltration. In addition, it was found that different SCNA status in CLDN10 might affect the level of immune cell infiltration. Furthermore, the expression of CLDN10 was significantly associated with the expression of several immune cell markers, especially B cell markers, follicular helper T cell (Tfh) markers and T cell exhaustion markers.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Down-regulated CLDN10 was associated with better overall survival (OS) in gastric cancer. And CLDN10 may serve as a potential prognostic biomarker and correlate to immune infiltration levels in gastric cancer.<\/jats:p>","DOI":"10.3389\/fgene.2021.747581","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:12:30Z","timestamp":1634148750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"XiongHui","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JianLong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhiHao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JianBao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZheHong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HuaiYu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuoqing","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.1158\/0008-5472.Can-05-1036","article-title":"Claudin-3 and Claudin-4 Expression in Ovarian Epithelial Cells Enhances Invasion and Is Associated with Increased Matrix Metalloproteinase-2 Activity","volume":"65","author":"Agarwal","year":"2005","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer J. Clinicians"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1002\/jcp.30263","article-title":"The Direct and Indirect Regulation of Follicular T Helper Cell Differentiation in Inflammation and Cancer","volume":"236","author":"Cao","year":"2021","journal-title":"J. Cel Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A Perspective on Cancer Cell Metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1164\/rccm.200803-456OC","article-title":"Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma","volume":"179","author":"Chao","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00259-010-1693-9","article-title":"AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual (7th Edition)","volume":"38","author":"Cuccurullo","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab Plus Ipilimumab in Advanced Non-small-cell Lung Cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.37294","article-title":"Tumor Copy Number Alteration burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and Death","volume":"7","author":"Hieronymus","year":"2018","journal-title":"Elife"},{"key":"B12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1349-7006.2003.tb01485.x","article-title":"Cell Adhesion System and Human Cancer Morphogenesis","volume":"94","author":"Hirohashi","year":"2003","journal-title":"Cancer Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00432-011-0987-z","article-title":"Expression of Claudin 10 Protein in Hepatocellular Carcinoma: Impact on Survival","volume":"137","author":"Huang","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11792","DOI":"10.1073\/pnas.1404671111","article-title":"Memory B Cells Contribute to Rapid Bcl6 Expression by Memory Follicular Helper T Cells","volume":"111","author":"Ise","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/jamaoncol.2019.6731","article-title":"Phase 1 Trial of Pembrolizumab Administered Concurrently with Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer","volume":"6","author":"Jabbour","year":"2020","journal-title":"JAMA Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1200\/jco.2017.76.6212","article-title":"CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients with Metastatic Esophagogastric Cancer","volume":"36","author":"Janjigian","year":"2018","journal-title":"Jco"},{"key":"B17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2016.00520","article-title":"Regulators of Tfh Cell Differentiation","volume":"7","author":"Jogdand","year":"2016","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/s0140-6736(17)31827-5","article-title":"Nivolumab in Patients with Advanced Gastric or Gastro-Oesophageal junction Cancer Refractory to, or Intolerant of, at Least Two Previous Chemotherapy Regimens (ONO-4538-12, ATTRACTION-2): a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"390","author":"Kang","year":"2017","journal-title":"The Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/s1470-2045(19)30626-6","article-title":"Nivolumab versus Chemotherapy in Patients with Advanced Oesophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy (ATTRACTION-3): a Multicentre, Randomised, Open-Label, Phase 3 Trial","volume":"20","author":"Kato","year":"2019","journal-title":"Lancet Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1462399406000056","article-title":"Claudins: Emerging Targets for Cancer Therapy","volume":"8","author":"Kominsky","year":"2006","journal-title":"Erm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbamem.2007.10.018","article-title":"Structure and Function of Claudins","volume":"1778","author":"Krause","year":"2008","journal-title":"Biochim. Biophys. Acta (Bba) - Biomembranes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for Analysis of Tumor-Infiltrating Immune Cells","volume":"48","author":"Li","year":"","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ol.2020.11557","article-title":"Claudin 10 Acts as a Novel Biomarker for the Prognosis of Patients with Ovarian Cancer","volume":"20","author":"Li","year":"","journal-title":"Oncol. Lett."},{"key":"B25","first-page":"175","article-title":"Claudins as Tight junction Proteins: the Molecular Element of Paracellular Transport","volume":"99","author":"Markov","year":"2013","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"key":"B26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbamem.2008.11.005","article-title":"Loss of Tight junction Barrier Function and its Role in Cancer Metastasis","volume":"1788","author":"Martin","year":"2009","journal-title":"Biochim. Biophys. Acta (Bba) - Biomembranes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fonc.2016.00055","article-title":"Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer","volume":"6","author":"Mereiter","year":"2016","journal-title":"Front. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/pmic.201100607","article-title":"Combining many Interaction Networks to Predict Gene Function and Analyze Gene Lists","volume":"12","author":"Mostafavi","year":"2012","journal-title":"Proteomics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab Plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/jco.2017.76.9901","article-title":"Durable Clinical Benefit with Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient\/Microsatellite Instability-High Metastatic Colorectal Cancer","volume":"36","author":"Overman","year":"2018","journal-title":"Jco"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","article-title":"Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"pg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression Profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.annonc.2021.02.005","article-title":"FAST: a Randomised Phase II Study of Zolbetuximab (IMAB362) Plus EOX versus EOX Alone for First-Line Treatment of Advanced CLDN18.2-positive Gastric and Gastro-Oesophageal Adenocarcinoma","volume":"32","author":"Sahin","year":"2021","journal-title":"Ann. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/path.1922","article-title":"Down-regulation of the Claudin-18 Gene, Identified through Serial Analysis of Gene Expression Data Analysis, in Gastric Cancer with an Intestinal Phenotype","volume":"208","author":"Sanada","year":"2006","journal-title":"J. Pathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00795-003-0219-y","article-title":"Tight Junctions and Human Diseases","volume":"36","author":"Sawada","year":"2003","journal-title":"Med. Electron Microsc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-017-0473-4","article-title":"Anti-claudin 18.2 Antibody as New Targeted Therapy for Advanced Gastric Cancer","volume":"10","author":"Singh","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ceb.2009.02.001","article-title":"Linking Somatic Genetic Alterations in Cancer to Therapeutics","volume":"21","author":"Stuart","year":"2009","journal-title":"Curr. Opin. Cel Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.addr.2005.01.006","article-title":"Role of Claudins in Tumorigenesis","volume":"57","author":"Swisshelm","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","article-title":"Cross-validation of Survival Associated Biomarkers in Gastric Cancer Using Transcriptomic Data of 1,065 Patients","volume":"7","author":"Sz\u00e1sz","year":"2016","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/onc.2016.289","article-title":"The Role of Claudins in Cancer Metastasis","volume":"36","author":"Tabari\u00e8s","year":"2017","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an Enhanced Web Server for Large-Scale Expression Profiling and Interactive Analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a Knowledge-Based Human Protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative Ipilimumab Plus Nivolumab in Locoregionally Advanced Urothelial Cancer: the NABUCCO Trial","volume":"26","author":"van Dijk","year":"2020","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: Analyzing Multi-Omics Data within and across 32 Cancer Types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA Prediction Server: Biological Network Integration for Gene Prioritization and Predicting Gene Function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.18632\/aging.102780","article-title":"Immune-related Key Gene CLDN10 Correlates with Lymph Node Metastasis but Predicts Favorable Prognosis in Papillary Thyroid Carcinoma","volume":"12","author":"Xiang","year":"2020","journal-title":"Aging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2217\/epi-2020-0256","article-title":"CLDN10 Associated with Immune Infiltration Is a Novel Prognostic Biomarker for clear Cell Renal Cell Carcinoma","volume":"13","author":"Yang","year":"2021","journal-title":"Epigenomics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1749-8090-8-95","article-title":"Expression of CLDN1 and CLDN10 in Lung Adenocarcinoma In Situ and Invasive Lepidic Predominant Adenocarcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"J. Cardiothorac. Surg."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.747581\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:12:33Z","timestamp":1634148753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.747581\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":48,"alternative-id":["10.3389\/fgene.2021.747581"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.747581","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"article-number":"747581"}}